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Background: Smoking is by far the most important cause of cancer that can be modified at the individual level.
Cancer incidence and mortality rates in Korea are the highest among all Asian countries, and smoking prevalence in
Korean men is one of the highest in developed countries. The purpose of the current study was to perform a
systematic review and provide an evidence-based assessment of the burden of tobacco smoking-related cancers in
the Korean population.
Methods: Sex- and cancer-specific population-attributable fractions (PAF) were estimated using the prevalence of
ever-smoking and second-hand smoking in 1989 among Korean adults, respectively, and the relative risks were
estimated from the meta-analysis of studies performed in the Korean population for ever-smoking and in the Asian
population for passive smoking. National cancer incidence data from the Korea Central Cancer Registry and national
cancer mortality data from Statistics Korea for the year 2009 were used to estimate the cancer cases and deaths
attributable to tobacco smoking.
Results: Tobacco smoking was responsible for 20,239 (20.9%) cancer incident cases and 14,377 (32.9%) cancer deaths
among adult men and 1,930 (2.1%) cancer incident cases and 1,351 (5.2%) cancer deaths among adult women in 2009
in Korea. In men, 71% of lung cancer deaths, 55%–72% of upper aerodigestive tract (oral cavity, pharynx, esophagus
and larynx) cancer deaths, 23% of liver, 32% of stomach, 27% of pancreas, 7% of kidney and 45% of bladder cancer
deaths were attributable to tobacco smoking. In women the proportion of ever-smoking-attributable lung cancer was
8.1%, while that attributable to second-hand smoking among non-smoking women was 20.5%.
Conclusions: Approximately one in three cancer deaths would be potentially preventable through appropriate control
of tobacco smoking in Korean men at the population level and individual level. For Korean women, more lung cancer
cases and deaths were attributable to second-hand than ever-smoking. Effective control programs against tobacco
smoking should be further developed and implemented in Korea to reduce the smoking-related cancer burden.
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Smoking is by far the most important single cause of
cancer in high-income countries [1]. According to the
International Agency for Research on Cancer (IARC),
tobacco smoking causes cancers of the oral cavity, phar-
ynx, esophagus, stomach, colon, rectum, liver, pancreas,
larynx, lung, cervix, kidney, bladder, ureter, and bone
marrow [2]. The first attempt to estimate the global
burden of cancer was performed by Doll and Peto using
US data, which provided the population-attributable
fraction (PAF) of smoking for cancer mortality [3]. Since
then, only a few studies have attempted to estimate the
relative importance of cancer risk factors including the
updated estimates of year 2000 [4-6]. Most previous
estimates of attributable cancers have been conducted
in high-resource countries, primarily Western coun-
tries and only a few studies were conducted in Asian
countries [7,8].
Smoking patterns and the magnitude of the increased
risk of lung cancer among smokers are very different in
Asian populations compared with those in Western pop-
ulations. The relative risks (RRs) of lung cancer observed
among Asian smokers are generally lower than those in
the Western population. Several possible explanations
for the differences in RRs among Asians and individuals
in Western countries have been suggested. They are a
longer duration of heavy smoking in Americans, a more
toxic formulation of American-manufactured cigarettes,
a higher efficiency of filters in Japanese cigarettes, lower
alcohol consumption by Japanese males, differences in
genetic susceptibility to tobacco carcinogens, and a higher
background risk of lung cancer among non-smokers [9].
The lung cancer mortality rates among non-smokers in
the Asian population (rate = 35.6 in Japanese men and
24.6 in Japanese women) were indeed shown to be higher
than those in the US (rate =15.7 in a CPS-I study and 14.7
in a CPS-II study) [10,11]. This raises an important ques-
tion regarding whether it would be appropriate to apply
the PAF estimated from studies performed in Western
populations to other countries. Thus, it would seem to be
essential to develop an estimate of the PAF of risk factors
for cancer that are specific to each region of the world.
Cancer is the leading cause of death in Korea; one
in every four Koreans becomes a victim of this life-
threatening disease. Furthermore, Korea has the high-
est cancer incidence and mortality rates among all East
Asian countries [12]. Among the evaluated cancer risk
factors, smoking is known to be the most important
factor that can be modified at the individual level.
Smoking prevalence has been very high among Korean
men. Although having continuously decreased from 70.8%
in 1992 to 46.7% in 2009 (Additional file 1: Figure S1), the
smoking prevalence in Korean men is still among the
highest in member countries of the Organisation forEconomic Co-operation and Development (OECD) [13,14].
Given very different patterns in the relative risks of tobacco
smoking for cancer in Asian and Western countries, the
importance of evaluating the region-specific PAF for
smoking in cancer should be recognized to develop
cancer prevention strategies tailored to each country.
The objective of the present study, thus, was to perform
a systematic review and provide an evidence-based
assessment of cancer incident cases and deaths attri-
butable to tobacco smoking, including both ever-and
second-hand smoking, in the Korean population using
nationwide cancer incidence and mortality data.
Methods
Definition of exposure
Tobacco smoking status was classified as “never”,
“former”, and “current” in this study. To describe the
cancer burden due to tobacco smoking, we considered
“ever-smoking” and “second-hand smoking”. We used
the term “ever-smoking” to mean “former” or “current”
smoking. Duration of smoking and cumulative con-
sumption (“pack-years”) were not considered in the
overall calculation of PAF. Exposure to second-hand
smoking was considered as exposed to smoking in the
household (smoking spouse or other family members)
and/or at the workplace. “Smokeless tobacco” is hardly
consumed in Korea, and thus was not taken into consid-
eration in this study. Because smoking is a risk factor
that can be avoided or completely suppressed, at least in
theory, PAF was estimated under the alternative scenario
of total absence of exposure [15].
Smoking prevalence in Korea
The burden of cancer observed in 2009 reflects past
exposure to risk factors. We assumed a latency period of
approximately 20 years between smoking exposure and
cancer occurrence. We estimated the adult smoking
prevalence separately by gender using the Korea National
Health Examination Survey (KNHES) performed in 1989.
The KNHES is a national survey on a random sample of
Koreans, designed to provide reliable nationwide statistics
on the state of health, health-related behavior, and percep-
tions. The prevalence rates of 11.7% of former smokers
and 70.8% of current smokers in Korean men and 0.3% of
former smokers and 3.9% of current smokers in Korean
women in 1989 were used [16]. A representative survey
on second-hand smoking has only been available from the
Korea National Health and Nutrition Examination Survey
(KNHANES) in recent years (Additional file 1: Figure S2).
We used the data for second-hand smoking prevalence
from 2007 to 2012 from KNHANES, and the prevalence
of current smoking during 2007–2012 to extrapolate
the passive smoking prevalence in 1989 through fitting
a log-linear regression model [17]. Because KNHES and
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and are publically available through on-line request
(http://knhanes.cdc.go.kr/knhanes/), we did not have to
address ethical concerns.
Relative risk of tobacco smoking
Relative risks (RRs) of smoking-related cancers were
evaluated for current smokers and former smokers com-
pared with never smokers from the analysis of a large-
scale population-based prospective study or by performing
a meta-analysis. The studies reporting RRs of smoking
and cancer published before August 1, 2012 were iden-
tified using databases including PubMed (http://www.
ncbi.nlm.nih.gov/pubmed/) and KoreaMed (http://www.
koreamed.org/SearchBasic.php). The search keywords
were “Korea”, “Asia”, “smoking”, “tobacco smoking”, “passive
smoking”, “secondhand smoke”, “environmental tobacco
smoke”, “risk”, and “cancer”. Language was limited to
English or Korean. At least two independent investiga-
tors performed literature search and reviewed articles.
Additional citations were identified from the references
of searched articles and information given by cancer
experts in Korea. When there were multiple reports of a
same study, publication with the longest follow-up
period or the largest event numbers was selected for
estimation of pooled RRs, to avoid bias. For ever-
smoking, 105 studies were initially identified, but many
of them were excluded in the final analysis for several
reasons: risk estimates with precision information (e.g.,
standard error, 95% confidence interval [CI]) were not
available, the classification for smoking was different
than never, former, and current smokers (53 studies),
and multiple results were reported from the same study
population (13 studies). Nineteen studies were used in
the final analysis to estimate the pooled RRs for ever-
smoking and the RRs for most cancer sites were esti-
mated from a few studies including a large-scale cohort
study [18-36]. When possible, the pooled RRs were
separately estimated for cancer incidence and mortality.
If a separate RR estimate for cancer mortality was not
available, we used the RR for cancer incidence in place of
RR for cancer mortality based on the assumption that
tobacco smoking does not affect cancer survival. When
the estimated RR was lower than one, we replaced the RR
by one because the cancer sites we considered in this
study are the ones that were convincingly classified as
carcinogens to human. Additional analysis results on
RRs from updated datasets with a longer follow-up
period and analyses adjusting for confounding variables
such as age and alcohol drinking were obtained through
personal communication with the authors of cited pub-
lications [21,27,31,35].
For oral cavity, pharynx, stomach and colorectal cancer,
there was no reliable RR estimates for women, hence RRof men was used for women instead. For estimation of the
RR for ever-smoking we used only studies conducted in
the Korean population (Additional file 1: Table S1 and S2).
However, for second-hand smoking, as the number of
Korean studies was limited, the study results from other
Asian countries such as China and Japan were consid-
ered in order to obtain reliable estimates. In total, risk
estimates from 19 studies were used for the meta-analysis
where pooled RR estimate of second-hand smoking were
calculated (Additional file 1: Table S3 and S4, Additional
file 1: Figure S3–S6) [37-58].
Meta-analyses were performed to estimate the pooled
RRs and 95% confidence intervals (CIs) based on both
fixed- and random-effects models. To check for hetero-
geneity, Q statistics and Higgin’s I2 value was used. We
considered that there existed heterogeneity among stud-
ies if the Q statistics was significant (p < 0.05) or I2 value
was above 75%. In case of heterogeneity, the risk esti-
mates from a random-effects model were used. Publica-
tion bias was checked by funnel plot and Begg’s test.
The “Metan” command in Stata (ver. 10.0; StataCorp,
College Station, TX, USA) and Comprehensive Meta-
Analysis version 2 (Biostat, Englewood, NJ, USA) were
used to perform the meta-analysis.
Cancer incidence and mortality data
The number of cancer incidence cases in 2009 in Korea
was obtained from the Korea Central Cancer Registry, a
population-based nationwide cancer registry in Korea [59].
Similarly, the number of cancer deaths in 2009 was ob-
tained using death certificate data from Statistics Korea
[60]. The cancers of interest were those that showed
convincing evidence for a positive association with tobacco
smoking and for which relative risk estimates in Korea
were available. Such cancers included oral cavity, pharynx,
esophagus, stomach, colorectum, liver, pancreas, larynx,
lung, cervix uterine, ovary, kidney, and bladder [61]. For
second-hand smoking, the only cancer retained in the ana-
lysis was lung cancer among never-smokers. When apply-
ing PAF to cancer incidence cases and deaths, we only
used the number of cases and deaths aged 20 years and
older because when assuming a latency of 20 years, to-
bacco causes no cancers below age 20 years, and the RRs
and smoking prevalence data reported in the literature
were estimated from adult study populations. Because we
used the aggregated data that do not contain personal in-
formation and that are publically available through website
(http://www.cancer.go.kr for cancer incidence statistics;
and http://www.kosis.kr for cancer mortality statistics), we
did not have to address ethical concerns.
Estimation of population attributable fraction
Estimation of attributable causes of cancer was made
through the proportion of cancers in the total population
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calculated by the following Levin’s formula for multiple
categories (k), as proposed by Hanley [62,63]:
PAF %ð Þ ¼
XK
k¼1pk RRk−1ð ÞXK
k¼1pk RRk−1ð Þ þ 1
 100; k ¼ 1; 2;…;K
where RR is the relative risk of cancer for smoking, p is
the smoking prevalence in the total adult population
(aged 20+ years), and K is the number of categories in
the smoking exposure.
The joint effect of second-hand smoking in the house-
hold and workplace was taken into account by assuming
the independence of exposure from two sources as
follows:
PAFHW ¼ PAFH  PAFW þ PAFH 1−PAFWð Þ
þ PAFW 1−PAFHð Þ
where PAFH and PAFW are the PAFs for passive smoking
exposure in the household and workplace, respectively
[64]. Derivation of second-hand smoking-related lung
cancer cases and deaths among never smokers is dem-
onstrated in Additional file 1: Table S5.
Sensitivity analysis for the estimation of population
attributable fraction (PAF) of tobacco smoking
To account for the uncertainty in PAF estimation arising
from the estimation of RRs for each cancer site, a sensi-
tivity analysis was performed under alternative scenarios
using the lower and upper limits of the 95% CIs of RR
estimates.
Results
Among all cancer sites reviewed in this study, laryngeal
cancer had the highest RR estimate (RR = 4.65 for current
smoking men and 9.10 for current smoking women for
cancer incidence; RR = 4.50 for current smoking men and
RR = 3.60 for current smoking women for cancer mortal-
ity, Table 1). The RR for lung cancer mortality among
current smokers was estimated to be 4.40 for men and
3.20 for women. For other cancer sites, the RRs for
current smokers ranged from 1.10 to 6.70 for cancer inci-
dence and from 1.10 to 3.30 for cancer mortality, except
for a few cases where the RR was estimated to be less than
one with insignificant p-values (Table 1). The results from
meta-analysis showed that the effect of second-hand
smoking on lung cancer incidence for men was not
significant, however, that for women showed a signifi-
cantly elevated risk of lung cancer incidence (RR = 1.32
for second-hand smoking at home; RR = 1.37 for second-
hand smoking at workplace, Table 2). Second-hand smok-
ing at home or in the workplace was responsible for 20.7%
of lung cancer incidence and 20.5% of lung cancer mortalityamong never-smoking women (994 lung cancer cases and
726 deaths). Among never-smoking men, 66 lung cancer
cases and 57 deaths were attributable to passive smoking
which showed a much lower PAF (5.9% for lung cancer in-
cidence and 10.5% for lung cancer mortality) in men than
that in women (Table 2).
Tobacco smoking was responsible for 14,377 (32.9%)
cancer deaths among adult men and 1,351 (5.2%) cancer
deaths among adult women in 2009 in Korea (Table 3).
Overall, 11.8% of all adult cancer cases and 22.7% of all
adult cancer deaths were attributable to either ever-
smoking or second-hand tobacco smoking. In men, 71%
of lung cancer deaths, 55%–72% of upper aerodigestive
tract (oral cavity, pharynx, esophagus and larynx) cancer
deaths, 23% of liver, 32% of stomach, 27% of pancreas,
7% of kidney and 45% of bladder cancer deaths were
attributable to tobacco smoking. In women, however,
ever-smoking-attributable lung cancer deaths were only
8.1% of the total lung cancer deaths. The PAF of second-
hand smoking (20.5%) exceeded that of ever-smoking in
Korean women because a large number of Korean
women were exposed to second-hand smoking either at
home (60%) or at workplace (15%), while ever-smoking
among Korean women was not very prevalent (0.3%
former smokers and 3.9% current smokers among
Korean women in 1989). As expected, lung cancer
comprised the greatest portion of all smoking-related
cancer cases in men (36%, (7244 + 66)/20239) and
women (66%, (278 + 994)/1930), followed by stomach
and liver cancers (Figures 1 and 2).
Sensitivity analysis showed that the PAF estimates
were more sensitive to the variation in RR in women
than in men when the upper and lower limits of the 95%
CI of RR was used, due to the larger uncertainty in the
estimation of RRs for women, particularly for oral cavity
and pharynx cancer (Figure 3).Discussion
Our study provides a systematic assessment of the bur-
den of smoking-related cancer in Korea in 2009. Overall,
among 187,894 cancer incident cases in Korean adults in
2009, 22,169 (11.8%) were attributable to tobacco smok-
ing. For cancer mortality, 15,728 of 69,431 (22.7%) cancer
deaths were attributable to tobacco smoking in Korea.
There was a large discrepancy between men and women
in the PAF estimates of cancer incidence (20.9% vs. 2.1%)
and cancer mortality (32.9% vs. 5.2%). Furthermore, the
PAF of smoking was higher for cancer mortality than for
cancer incidence. This is because smoking-related cancers,
such as lung, liver, and pancreas cancer, tend to have a
poor prognosis. Three in ten cancer deaths among Korean
adult males in 2009 could have been prevented had there
been no smokers in Korea. In particular, 71% of all lung
Table 1 Relative risk for tobacco smoking and cancer in Korea
Cancer site (ICD-10) Gender Pooled RR (95% CI) Sources of
pooled RR (OR)Incidence Mortality
Former smokers Current smokers Former smokers Current smokers
Oral Cavity (C00-C09)a Men 1.03 (0.63-1.68) 2.19 (1.54-3.12) 0.80 (0.10-13.50) 3.30 (0.50-34.60) [20,21]
Women - 6.70 (1.10-39.40)b 0.80 (0.10-13.50)c 3.30 (0.50-34.60)c [21]
Pharynx (C10-C14)a Men 1.03 (0.63-1.68) 2.19 (1.54-3.12) 0.80 (0.10-13.50) 3.30 (0.50-34.60) [20,21]
Women - 6.70 (1.10-39.40)b 0.80 (0.10-13.50)c 3.30 (0.50-34.60)c [21]
Esophagus (C15) Men 1.20 (1.05-1.37) 2.23 (1.99-2.50) 1.45 (1.21-1.73) 2.64 (2.25-3.09) [20,21,26]
Women 1.10 (0.40-3.10) 1.60 (0.80-3.10) 1.60 (0.60-5.10) 0.90 (0.30-2.70) [21]
Stomach (C16) Men 1.22 (0.87-1.71) 1.51 (1.46-1.55) 1.31 (1.21-1.41) 1.60 (1.51-1.71) [20,21,23,27,28,34]
Women 1.22 (0.87-1.71)c 1.51 (1.46-1.55)c 1.01 (0.83-1.24) 1.04 (0.85-1.26) [21,27]
Colorectum (C18-C20) Men 1.13 (1.02-1.26) 0.98 (0.78-1.23) 1.10 (0.90-1.40) 1.10 (0.80-1.40) [20,21,24,33]
Women 1.07 (0.70-1.63) 0.97 (0.76-1.25) 1.10 (0.90-1.40)c 1.10 (0.80-1.40)c [24,33]
Liver (C22) Men 1.20 (1.10-1.30) 1.40 (1.30-1.50) 1.20 (1.00-1.30) 1.40 (1.30-1.60) [21]
Women 0.80 (0.10-5.60) 2.50 (1.00-6.30) 1.90 (0.30-14.20) 2.60 (0.60-11.00) [21]
Pancreas (C25) Men 1.20 (1.00-1.40) 1.50 (1.30-1.70) 1.11 (0.93-1.33) 1.50 (1.31-1.71) [21,27]
Women 0.80 (0.50-1.10) 1.20 (0.90-1.50) 0.90 (0.5-1.20) 1.10 (0.80-1.40) [21]
Larynx (C32) Men 2.01 (1.49-2.73) 4.65 (3.61-6.00) 1.70 (1.00-2.90) 4.50 (2.80-7.10) [20,21]
Women 0.90 (0.10-6.80) 9.10 (4.60-17.80) 0.90 (0.10-6.90) 3.60 (1.30-9.70) [21]
Lung (C33-C34) Men 1.21 (0.87-1.69) 2.58 (1.83-3.63) 1.82 (1.63-2.03) 4.40 (3.98-4.87) [19-21,25,27,30,31,36]
Women 1.65 (1.37-1.99) 2.37 (2.09-2.68) 1.90 (1.50-2.40) 3.20 (2.70-3.70) [21,31]
Cervix uteri (C53) Women 1.15 (0.87-1.52) 1.12 (0.92-1.35) 1.20 (0.60-2.40) 1.80 (1.10-2.80) [18,20,21,35]
Ovary (C56) Women 1.12 (0.90-1.39) 2.07 (1.65-2.60) 1.12 (0.90-1.39)d 2.07 (1.65-2.60)d [22,29]
Kidney (C64) Men 1.10 (0.90-1.20) 1.10 (0.90-1.20) 1.00 (0.70-1.40) 1.10 (0.80-1.50) [21]
Women 1.10 (0.60-2.10) 1.00 (0.60-1.60) 2.30 (0.90-6.30) 1.50 (0.60-3.90) [21]
Bladder (C67) Men 1.50 (1.30-1.70) 2.00 (1.70-2.30) 1.30 (0.90-1.90) 2.10 (1.40-2.90) [21]
Women 0.92 (0.53-1.58) 1.73 (1.26-2.38) 0.70 (0.20-2.20) 2.00 (1.10-3.80) [21,32]
aRR for cancers of the oral cavity and pharynx combined was used; bRR for ever-smoker (past + current smokers); cRR for men was used for women; dRR for
incidence was used.
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prevented if no man had smoked in Korea.
The PAF of tobacco smoking for cancer mortality in
Korean men was 33%, which was very similar to previ-
ous reports in France (33%), Japan (34%) and China
(33%), and somewhat different from the UK (24%), a
country in which smoking prevalence among men has
decreased for several decades [5-8]. Interestingly, the
overall cancer burden related to smoking in men in
Korea is at about the same level as in France, Japan and
China, although the RRs for current smokers are much
lower in Korea, Japan and China than in France. It
seems that the high smoking prevalence among Asian
men adds to the smoking-attributable cases, while RRs
have been observed to be lower in Asia than in Western
countries. These results of comparison support the
necessity of ethnic- or country-specific evaluation of the
PAF because even though the overall PAF appear to be
same, the exposure prevalences and the relative riskscan be different across countries, therefore, the preven-
tion strategy in each country should be also different.
However, the PAF for Korean women appears to be
much lower than France and UK, and somewhat lower
than in China or Japan (Table 4). While the PAFs of lung
cancer mortality for ever-smoking among men were very
similar across three Asian countries, namely Korea,
Japan and China, the PAFs among women were rather
different. This seems to be due to the lower smoking
prevalence and slightly lower RRs among Korean adult
women compared to Japanese or Chinese women. Peto
et al. estimated the cancer mortality attributable to
smoking in 40 developed countries [65]. The estimates
in the Central Asian population were 34% for men and
4% for women. Our Korean estimates were compatible
with their figures.
The relative risks for smoking in Korea were much
lower compared to those reported in Western countries,
but rather similar to Japan or China (Table 4). This trend
Table 2 Lung cancer cases and deaths among never-smokers attributable to passive smoking in Korea (2009)
Gender Prevalencea (%) of
passive smoking
RRb for
lung cancer
PAF (%) Lung cancer incidence cases/
deaths among never-smokers
Passive smoking-related
lung cancer cases/deaths
Sources of pooled RR
Incidence
Exposure to smoking at home Men 14.8 1.00 (0.67-1.48) - 1,109 0 [37,52,53]
Women 60.1 1.32 (1.13-1.55) 16.3 4,809 783 [37-44,46,47,49-51,53,55-58]
Exposure to smoking at workplace Men 42.2c 1.15 (0.74-1.77) 5.9 1,109 66 [52]
Women 14.7c 1.37 (1.18-1.60) 5.2 4,809 251 [42,44,51,55-58]
Exposure to smoking at home or workplace Men 5.9 1,109 66
Women 20.7 4,809 994
% of all cancers Men 0.1
Women 1.1
Mortality
Exposure to smoking at home Men 14.8 1.34 (0.82-2.17) 4.8 544 26 [48]
Women 60.1 1.32 (0.95-1.83) 16.1 3,543 571 [45,48]
Exposure to smoking at workplaced Men 42.2c 1.15 (0.74-1.77) 5.9 544 32 [52]
Women 14.7c 1.37 (1.18-1.60) 5.2 3,543 185 [42,44,51,55-58]
Exposure to smoking at home or workplace Men 10.5 544 57
Women 20.5 3,543 726
% of all cancers (aged 20+ years) Men 0.1
Women 2.8
aPrevalence of passive smoking at home or workplace was estimated by extrapolating the data from the Korea National Health and Nutrition Examination Survey in 2007, 2008, 2009, 2010, 2011 and 2012. [17].
bRRs obtained from a meta-analysis.
cPrevalence for passive smoking at the workplace in the Korean population was calculated by exposure prevalence at the workplace ×% employed adults in Korea in 1989: 71.2% in men, 45.7% in women (Statistics
Korea) [60].
dRR for cancer incidence was used for cancer mortality.
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Table 3 Estimated number of cancer incidence cases and deaths attributable to tobacco smoking in Korea
Cancer site Men Women Total
PAF (%) Cases PAF (%) Deaths PAF (%) Cases PAF (%) Deaths PAF (%) Cases PAF (%) Deaths
Oral cavity 45.8 517 62.0 246 18.2 93 8.2 13 37.2 610 47.1 259
Pharynx 45.8 322 62.0 228 18.2 20 8.2 5 42.0 342 55.1 233
Esophagus 47.2 919 54.8 711 2.3 3 0.2 0 44.0 922 50.6 711
Stomach 27.9 5,514 31.6 2,107 2.0 193 0.2 5 19.4 5,707 20.8 2,112
Colorectum 1.5 224 1.2 45 0.0 1 0.4 13 0.9 225 0.8 58
Liver 23.5 2,737 23.5 1,976 5.5 213 6.1 172 19.0 2,950 19.1 2,148
Pancreas 27.4 646 26.8 598 0.8 15 0.4 7 15.5 661 14.9 605
Larynx 73.0 782 71.9 275 24.0 16 9.2 4 70.2 798 65.8 279
Lung 53.3 7,244 71.5 7,783 5.2 278 8.1 327 39.8 7,522 54.4 8,110
Among non-smokers 5.9 66 10.5 57 20.7 994 20.5 726 17.9 1,060 19.2 783
Cervix uteri 0.5 19 3.1 30 0.5 19 3.1 30
Ovary 4.0 68 4.0 34 4.0 68 4.0 34
Kidney 7.6 175 6.6 33 0.0 0 2.3 5 5.2 175 5.1 38
Bladder 43.4 1,093 44.9 318 2.8 17 3.8 10 35.4 1,110 34.0 328
Total 20.9 20,239 32.9 14,377 2.1 1,930 5.2 1,351 11.8 22,169 22.7 15,728
% of all cancers (aged 20+ years) 20.9 32.9 2.1 5.2 11.8 22.7
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the RR for kidney cancer was also relatively lower in
Korea than other countries. The lung cancer risks
observed among smokers in Asians are in general
much lower than those in the Western population. A
meta-analysis by Gandini et al. showed that smokers
are at almost 10-fold elevated risk of developing lung
cancer compared to never smokers in Caucasians, andFigure 1 Number of cancer incident cases attributable to tobacco sm
cases attributable to tobacco smoking; B) Number of cancer incident cases10-fold increase in African-Americans [66]. On the
contrary, the lung cancer risk among current smokers
is about four times the risk among never smokers in
Asian countries such as Japan, China and Korea [67].
Furthermore, lung cancer rates in American men have
greatly exceeded those in Japanese men for several
decades despite the higher smoking prevalence in Japanese
men, which was noted as “Japanese smoking paradox”.oking in Korean men, 2009*. * A) Proportion of cancer incident
attributable to tobacco smoking by cancer sites.
Figure 2 Number of cancer incident cases attributable to tobacco smoking in Korean women, 2009*. * A) Proportion of cancer incident
cases attributable to tobacco smoking; B) Number of cancer incident cases attributable to tobacco smoking by cancer sites.
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http://www.biomedcentral.com/1471-2407/14/406A multicentric case–control study involving both Ameri-
cans and Japanese was carried out and showed a striking
results that the odds ratio (OR) of current US smokers
relative to never smokers was 40.4, that was about 6 to 10
times higher than the OR ranging between 3.5 and 6.3 in
current Japanese smokers [68].
Epidemiologists have hypothesized that following may
be possible explanations for these differences. First, manyFigure 3 Sensitivity analysis of the PAF for tobacco smoking using th
risks. Note: the length of shaded bars represent the estimated PAF values
estimated using the lower and upper limits of 95% confidence interval forEuropean countries and the U.S. began to experience their
tobacco epidemic in 1920s, after World War I, appro-
ximately 30 years earlier than Asian countries [69]. In
Korea, cigarette consumption has risen sharply since the
end of Korean War in 1953, and the present rates of
tobacco-caused disease in Asian countries should not be
interpreted as reflecting lesser risks for smoking of Asian
cigarettes. Second, ages at initiation of smoking aree lower and upper limits of 95% confidence interval for relative
when RRs in Table 1 were used and the intervals represent the PAF
RRs.
Table 4 International comparison of PAF (%) of cancer deaths for tobacco smoking
Cancer site (ICD-10 ) Republic of Korea Japan [7] China [8] France [5] United Kingdom [6]
Men Women Men Women Men Women Men Women Men Women
RR PAF RR PAF RR PAF RR PAF RR PAF RR PAF RR PAF RR PAF RR PAF RR PAF
Oral Cavity (C00-C09) 3.3 62.0 3.3 8.2 2.4 50.0 1.8 8.5 1.5b 24.6 1.5a 2.8 4.2 63.1 1.6 17.0 10.9 70 5.1 55
Pharynx (C10-C14) 6.8 76.0 3.3 44.1
Esophagus (C15) 2.6 54.8 0.9 0.2 3.0 58.9 2.4 14.7 1.3c 17.9 1.3a 1.9 2.5 51.1 2.3 34.4 6.8 63 7.8 71
Stomach (C16) 1.6 31.6 1.0 0.2 1.4 23.5 1.3 3.4 1.7c 30.9 1.7a 3.8 1.7 31.1 1.5 14.3 2.2 26 1.5 15
Colorectum (C18-C20) 1.1 1.2 1.1 0.4 1.4 20.4 1.4 4.5 1.24 7 1.3 10
Liver (C22) 1.4 23.5 2.6 6.1 1.7 35.1 1.6 6.8 1.4b 18.7 1.2b 1.0 1.9 37.5 1.5 17.1 2.3 27 1.5 15
Pancreas (C25) 1.5 26.8 1.1 0.4 1.4 23.9 1.9 9.5 1.9c 35.5 1.9a 4.6 1.6 24.9 1.6d 17.0 2.2 26 2.2 31
Larynx (C32) 4.5 71.9 3.6 9.2 4.5 71.9 4.5 30.1 1.5b 24.6 1.5a 2.8 5.2 75.9 5.2d 64.8 14.6 79 13 79
Lung (C33-C34) 4.4 71.5 3.2 8.1 3.6 67.5 3.6 23.9 5.7c 75.0 5.0c 18.4 9.9 83.0 7.6 69.2 21.3 87 12.5 84
Cervix (C53) - - 1.8 3.1 - - 2.0 10.9 - - 1.8e 4.5 - - 1.8 22.9 - - 1.5 7
Ovary (C56) - - 2.1 4.0 - - 0.9 - - - 2.1 3
Kidney (C64) 1.1 6.6 1.1 2.3 1.5 27.9 0.9 - 1.6 26.4 1.4 11.5 2.5g 29g 1.5g 15g
Bladder (C67) 2.1 44.9 2.0 3.8 4.3f 70.7f 1.3f 3.6f 1.9b 36.8 1.7b 3.6 2.8 52.8 2.7 39.3 3 38 2.4 34
Myeloid leukemia (C92) - - - - 1.7 33.5 1.0 - 1.9 19 1.2 6
Prevalence (%) 70.8 (11.7)h 3.9 (0.3)h 53.1 (19.8)i 9.7 (2.6)i 64.0j 5.6j 48.2k 30.4k 22l 21l
% of all cancers 32.9 5.2 34.4 6.2 32.7 5.0 33.4 9.6 23.0 15.6
aReplaced by men’s RR.
bRR of cancer mortality associated with smoking. SE for RR (not 95% CI) is provided in Liu’s retrospective proportional mortality study (involving cancer of oral cavity, pharynx and larynx).
cRR of cancer incidence associated with smoking.
dWhen RRs for women were higher than for men or when no RR was estimable for women, the RR for men was used instead.
eRR not derived from Chinese studies.
fRenal pelvis, Ureter, Bladder (C65-68).
gKidney and renal pelvis.
hPrevalence data for 1989 derived from the Korea National Health Examination Survey, current smoker’s prevalence and parenthesis represent former smoker’s prevalence.
iPrevalence data for 1990 derived from the National Nutrition Survey, current smoker’s prevalence and parenthesis represent former smoker’s prevalence.
jPrevalence data for ever-smoking and involuntary smoking of 1990 was estimated by linear interpolation using the results of these two national surveys.
kPrevalence data for 1985 were estimated by linear interpolation using results of surveys conducted in 1983 and 1986 (current smoker).
lPrevalence data for 2008 derived from General Lifestyle Survey 2008/ONS 2010 (current smoker).
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http://www.biomedcentral.com/1471-2407/14/406different. Korean smokers in all age groups started smok-
ing later than their counterparts in Western countries, and
they differed even more among female smokers [70].
Third, higher background risk of lung cancer among
never-smokers is observed in Asians than individuals in
Western countries. The lung cancer mortality rates among
never smokers in Asian population (Rate = 35.6 in Japanese
men; 24.6 in Japanese women) were indeed shown to be
much higher than those in the US (Rate = 15.7 in CPS-I
study; Rate = 14.7 in CPS-II study) [10,11,71].
According to a recent report on the mortality attribut-
able to tobacco by World Health Organization, the esti-
mated proportion of deaths from all malignant neoplasm
attributable to tobacco was 35% for both sexes, 44% for
men and 18% for women aged 30+ years in the Republic
of Korea, which were higher than our estimates [72].
We also found that 20.7% of lung cancer cases among
never smoking women were attributable to second-hand
smoking from the home or workplace, and it is quite
striking that the number of lung cancer incident cases
(994 cases) related to second-hand smoking among
never smoking women was about 3 times higher than
that among smoking women (278 cases).
Our study has several strengths. First, we used nation-
wide cancer incidence and mortality data that achieve
a nearly complete coverage of the Korean population.
With well-established nationwide cancer and mortality
registry systems, we had access to precise numbers of
gender- and site-specific cancer cases and cancer deaths
for PAF estimation. Second, the RR estimates for smok-
ing and cancer used in our study were mostly derived
from a very large-scale population-based cohort study
with over 1,210,000 Korean subjects, giving reliable RR
estimates that were also adjusted for confounding vari-
ables such as age and alcohol drinking. Therefore we
believe that the potential bias of overestimating the PAF
was minimized in our estimation. Third, the smoking
prevalence was also obtained from national health survey
data with a representative sample in 1989, which allowed
for an induction period of 20 years.
Despite the strengths of our study, we acknowledge
the limitations that might have resulted in underestimat-
ing smoking-attributable cancer fraction. A recent evalu-
ation of smoking-related cancers also listed ureter and
bone marrow cancers [2], but we did not include these
because of lack of evidence of an increased RR in the
Korean population. Furthermore, smoking in Korean
women in 1989 might have been under-reported, because
the survey was done through a personal interview, and
smoking women were not culturally well-accepted, based
on social norms in 1989 in Korea. Another limitation
is that the restriction of our RR estimation to studies
performed on Korean populations limited the number of
studies included, which may have introduced slightlyhigher uncertainty in the pooled estimate of RRs. How-
ever, the PAFs were calculated from studies including a
very large-scale population-based prospective study
with over 1 million subjects, therefore we believe that
the degree of uncertainty in our RR and PAF estimation
was reduced.
Conclusions
While the smoking prevalence in male adults has been
decreasing in Korea, it remains among the highest of the
developed countries. Because Korea is quickly approaching
the status of an aged society, the number of cancer cases
and deaths are expected to increase in the future. Further-
more, while lung cancer incidence rates have stabilized
in men during recent years, those in women show a
significantly increasing trend (annual percent change of
1.5%), which might reflect the fact that the smoking
prevalence in women is increasing [59]. Approximately
one out of three cancer deaths and two out of three lung
cancer deaths in Korean men in 2009 could have been
prevented had there been no smokers. And one out of four
lung cancer cases among non-smoking Korean women
could have been prevented if there had been no smokers.
Considering the high prevalence of male smokers and
increasing prevalence of young female smokers, effective
control programs against tobacco smoking should be
further developed and implemented in Korea to reduce
the smoking-related cancer burden.
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